Health Encyclopedia

Home | List of Topics | General Medical Information | Tests

LH response to GnRH

Definition

LH response to GnRH is a blood test to indirectly determine the pituitary gland's ability to appropriately respond to gonadotropin releasing hormone (GnRH), a hormone produced in the hypothalamus.

Alternative Names

Luteinizing hormone response to gonadotropin-releasing hormone

How the test is performed

A blood sample is drawn prior to an injection of GnRH. After a specified time, other blood samples are drawn so that LH can be measured.

Blood is drawn from a vein, usually from the inside of the elbow or the back of the hand. The site is cleaned with germ-killing medicine (antiseptic). The health care provider wraps an elastic band around the upper arm to apply pressure to the area and make the vein swell with blood.

Next, the health care provider gently inserts a needle into the vein. The blood collects into an airtight vial or tube attached to the needle. The elastic band is removed from your arm.

Once the blood has been collected, the needle is removed, and the puncture site is covered to stop any bleeding.

In infants or young children, a sharp tool called a lancet may be used to puncture the skin and make it bleed. The blood collects into a small glass tube called a pipette, or onto a slide or test strip. A bandage may be placed over the area if there is any bleeding.

How to prepare for the test

No special preparation is necessary.

How the test will feel

When the needle is inserted to draw blood, some people feel moderate pain, while others feel only a prick or stinging sensation. Afterward, there may be some throbbing.

Why the test is performed

This test is used to tell the difference between primary and secondary hypogonadism.

• Primary hypogonadism starts in the testicle or ovary.
• Secondary hypogonadism starts in the hypothalamus or pituitary gland.

This test may be also be done to evaluate low testosterone levels in men or low estradiol levels in women.

Normal Values

• Children: less than 2.0 international units per milliliter (IU/mL)
• Male: 0.9 to 10.6 IU/mL
• Female; follicular phase of the menstrual cycle: 1.1 to 11.1 IU/mL
• Female; mid-cycle: 17.5 to 72.9 IU/mL
• Female; luteal phase of the menstrual cycle; 0.4 to 15.1 IU/mL
• Female; postmenopause: 6.8 to 46.6 IU/mL

Note: Normal value ranges may vary slightly among different laboratories. Talk to your doctor about the meaning of your specific test results.

What abnormal results mean

An excessive LH response suggests that gonadal failure is due to a problem within the ovaries or testes.

A reduced LH response suggests a problem with the hypothalamus or pituitary gland.

Abnormal results may also be due to:

• Gonadotropin deficiency, may be seen in patients with:
  • Large pituitary tumors
  • Endocrine deficiency
  • Hemochromatosis
• Kallmann syndrome
• Hyperprolactinemia
• Amenorrhea
• Anorexia nervosa
• Starvation

What the risks are

Veins and arteries vary in size from one patient to another and from one side of the body to the other. Obtaining a blood sample from some people may be more difficult than from others.

Other risks related to having blood drawn are rare but may include:

• Excessive bleeding
• Fainting or feeling lightheaded
• Hematoma (blood accumulating under the skin)
• Infection (a slight risk any time the skin is broken)

Special considerations

In women, estrogen levels rise during the menstrual cycle until there is enough estrogen present to stimulate the release of GnRH and lutenizing hormone (LH).

Progesterone in high concentrations (for example, during the luteal phase of the menstrual cycle or during pregnancy) reduces the response of the pituitary gland to GnRH.

Review Date:8/17/2007
Reviewed By:Melanie N. Smith, M.D., Ph.D., Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA. Review provided by VeriMed Healthcare Network.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The Agency for Health Care Administration (Agency) and this website do not claim the information on, or referred to by, this site is error free. This site may include links to websites of other government agencies or private groups. Our Agency and this website do not control such sites and are not responsible for their content. Reference to or links to any other group, product, service, or information does not mean our Agency or this website approves of that group, product, service, or information.

Additionally, while health information provided through this website may be a valuable resource for the public, it is not designed to offer medical advice. Talk with your doctor about medical care questions you may have.